Jackson LA - Search Results

1

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.

Keitel WA, Jackson LA, Edupuganti S, Winokur PL, Mulligan MJ, Thornburg NJ, Patel SM, Rouphael NG, Lai L, Bangaru S, McNeal MM, Bellamy AR, Hill HR; VTEU H3N2v Vaccine Study Work Group. Keitel WA, et al. Among authors: jackson la. J Infect Dis. 2015 Aug 15;212(4):552-61. doi: 10.1093/infdis/jiv056. Epub 2015 Feb 3. J Infect Dis. 2015. PMID: 25649171 Free PMC article.

2

Diphtheria antitoxin levels among children primed with a diphtheria and tetanus toxoids and acellular pertussis vaccine lot with a subpotent diphtheria toxoid component.

Jackson LA, Falls S, Yu O, George J, Pietrobon PJ, Rubanowice D, Froeschle J. Jackson LA, et al. J Infect Dis. 2001 Jun 1;183(11):1698-700. doi: 10.1086/320713. Epub 2001 May 9. J Infect Dis. 2001. PMID: 11343223

3

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors.

Jackson LA, Austin G, Chen RT, Stout R, DeStefano F, Gorse GJ, Newman FK, Yu O, Weniger BG; Vaccine Safety Datalink Study Group. Jackson LA, et al. Vaccine. 2001 Sep 14;19(32):4703-9. doi: 10.1016/s0264-410x(01)00225-0. Vaccine. 2001. PMID: 11535320 Clinical Trial.

4

Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.

Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, Dunn J, DeStefano F, Shay D. Neuzil KM, et al. Among authors: jackson la. J Infect Dis. 2006 Oct 15;194(8):1032-9. doi: 10.1086/507309. Epub 2006 Sep 11. J Infect Dis. 2006. PMID: 16991077 Clinical Trial.

5

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.

Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Simonsen L, et al. Among authors: jackson la. Lancet Infect Dis. 2007 Oct;7(10):658-66. doi: 10.1016/S1473-3099(07)70236-0. Lancet Infect Dis. 2007. PMID: 17897608 Review.

6

Pneumococcal vaccination of elderly adults: new paradigms for protection.

Jackson LA, Janoff EN. Jackson LA, et al. Clin Infect Dis. 2008 Nov 15;47(10):1328-38. doi: 10.1086/592691. Clin Infect Dis. 2008. PMID: 18844484 Free PMC article. Review.

7

Using surveillance to evaluate influenza vaccine effectiveness.

Jackson LA. Jackson LA. J Infect Dis. 2009 Jan 15;199(2):155-8. doi: 10.1086/595863. J Infect Dis. 2009. PMID: 19086916 No abstract available.

8

A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents.

Jackson LA, Jacobson RM, Reisinger KS, Anemona A, Danzig LE, Dull PM. Jackson LA, et al. Pediatr Infect Dis J. 2009 Feb;28(2):86-91. doi: 10.1097/INF.0b013e31818a0237. Pediatr Infect Dis J. 2009. PMID: 19116603 Clinical Trial.

9

Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study.

Jackson LA, Baxter R, Naleway AL, Belongia EA, Baggs J. Jackson LA, et al. BMC Infect Dis. 2009 Mar 25;9:37. doi: 10.1186/1471-2334-9-37. BMC Infect Dis. 2009. PMID: 19321001 Free PMC article.

10

Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.

Jackson LA, Baxter R, Reisinger K, Karsten A, Shah J, Bedell L, Dull PM; V59P13 Study Group. Jackson LA, et al. Clin Infect Dis. 2009 Jul 1;49(1):e1-10. doi: 10.1086/599117. Clin Infect Dis. 2009. PMID: 19476428 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

406 results

Search Page